News & Insights
Stay Informed With Our Latest Updates
Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.
Firm News May 5, 2026
Gibson Dunn Advised KKR as Lead Investor in $125 Million Series C Funding Round of Reserv
Gibson Dunn advised KKR as lead investor in the $125 million Series C funding round of Reserv Inc.
Firm News December 19, 2025
Gibson Dunn Advised J.P. Morgan Asset Management as Co-Lead Investor in Series L Financing Round of Databricks
Gibson Dunn advised J.P. Morgan Asset Management as co-lead investor in the Series L financing round of Databricks.
Firm News October 23, 2025
Gibson Dunn Advised Nextech Ventures and EQT Life Sciences in $183 Million Series C Financing for Electra Therapeutics
Gibson Dunn advised Nextech Ventures and EQT Life Sciences as co-lead investors in a $183 million Series C financing for Electra Therapeutics, a clinical stage biotechnology company pioneering therapies against novel targets for diseases in immunology and cancer.
Firm News October 14, 2025
Gibson Dunn Advises KKR on Participation in Series A Financing Round of Expedition Therapeutics
Gibson Dunn advised KKR in connection with its participation in the Series A financing round of Expedition Therapeutics, Inc., an …
Firm News July 23, 2025
Gibson Dunn Advised Blueflame AI on Its Sale to Datasite
Gibson Dunn advised Blueflame AI, a leading provider of agentic AI solutions for investment and financial services, on its sale to Datasite, the global SaaS provider of AI-powered workflow collaboration and automation solutions for M&A, investment, and strategic projects.
Firm News July 18, 2025
Gibson Dunn Advised Blue Earth Capital on Series B Funding Round for GeologicAI
Gibson Dunn advised Blue Earth Capital on the $44 million Series B funding round of GeologicAI, a leader in applying advanced AI and high-resolution decision engineering to the critical minerals mining industry
Firm News February 13, 2025
Gibson Dunn Advises J.P. Morgan on Participation as Lead Investor in Series C Financing Round of Olipop
Gibson Dunn advised J.P. Morgan on its participation as lead investor in the Series C financing round of Olipop, a prebiotic beverage company.
Client Alert May 8, 2023
M&A Report: Delaware Court of Chancery Declines to Enforce a Covenant Not to Sue Upon Exercise of a Drag-Along Right for Public Policy Reasons
Gibson Dunn lawyers discuss a ruling by the Delaware Court of Chancery that a covenant not to sue cannot shield defendants from tort liability for intentional harm.